Insider · CIK 0000882095
GILEAD SCIENCES, INC.
owner
Files at ASMB (ASSEMBLY BIOSCIENCES, INC.), XLO (Xilio Therapeutics, Inc.). First filing Dec 19, 2024, latest Dec 23, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
2 / 0
$22M bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 50Moderate | buy 2 | ASMB ASSEMBLY BIOSCIENCES, INC. | $20M | 940,499 | +74% | - | |
| 38Weak | buy | XLO Xilio Therapeutics, Inc. | $1.8M | 1,759,978 | +24% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 19, 2024 | ASMB ASSEMBLY BIOSCIENCES, INC. | POpen-market purchase Common Stock | +940,499 | $21.37 | $20M | 2,209,471 | Dec 23, 2024 |
| Dec 18, 2024 | XLO Xilio Therapeutics, Inc. | POpen-market purchase Common Stock | +1,759,978 | $1.04 | $1.8M | 9,105,451 | Dec 19, 2024 |
| Dec 18, 2024 | XLO Xilio Therapeutics, Inc. | POpen-market purchase Prefunded Warrants (right to buy)derivative | +6,092,816 | $1.04 | $6.3M | 9,975,266 | Dec 19, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.